arXiv Machine Learning

Certifying when decision-time information justifies adaptive experimentation

arXiv:2607. 27651v1 Announce Type: new Abstract: Adaptive laboratories choose measurements during experiments, yet most methods begin after adaptation is permitted.

arXiv Machine Learning
Jun 3

Fairness Definitions and Metrics in Deep Reinforcement Learning for Drug Discovery in Healthcare: A Rapid Evidence Review

arXiv:2606. 02902v1 Announce Type: cross Abstract: Deep reinforcement learning (DRL) is increasingly applied to de novo molecular design, but choices in data, rewards, and evaluation can yield uneven performance across disease areas and chemotypes.

By Esmaeil Shakeri, Ronnie de Souza Santos, Behrouz Far
arXiv AI
Jul 8

Evaluating calibrated refusal and safe usefulness in dual-use biology settings

arXiv:2607. 05462v1 Announce Type: cross Abstract: As AI agents are incorporated into life science workflows, the capabilities that speed discovery might also enable misuse.

By Edwin H. Wintermute, Harmon Bhasin, Christina M. Agapakis, Dianzhuo Wang, Evan Seeyave, Arjun Banerjee, Daniel Fulop, Matthew C. Watson, Adam J. Meyer, Sandrine Boissel, Jens H. Kuhn, Rishi Jain, Noah D. Taylor, Helena Shomar, Patrick M. Boyle, Kenny Workman
arXiv AI
Aug 11

From Trajectories to Evidence: Auditable Experimental Records for Industrial Research Agents

arXiv:2608. 05235v1 Announce Type: cross Abstract: Research agents increasingly conduct multi-round machine-learning experiments in industrial recommendation settings and retain the resulting trajectories to guide later decisions.

By Zijie Zhuang, Changxin Lao, Pengbo Xu, Hanwen Xu, Ruochen Yang, Yingzhi He, Peng Zhang, Jiangxia Cao, Yusheng Huang, Guohong Mu, Jian Liang, Ruiming Tang, Shuang Yang, Zhaojie Liu, Wenwu Ou, Kun Gai
Hugging Face Trending Papers
Jul 20

An Early Warning of Emerging Biosecurity Risks in Frontier LLMs

Frontier large language models (LLMs) are increasingly integrated into scientific workflows, yet their growing biological capabilities may outpace current safeguards. To assess the biological risks of frontier models, we develop Intern-BioBreaker, a specialized bio-red-teaming model, together with an integrated computational-to-physical framework that couples model-level stress testing with wet-lab validation.

arXiv AI
Jun 2

Probe Before You Edit: Probing-Guided Molecular Optimization for LLM Agents in Structure-Based Drug Design

arXiv:2606. 00555v1 Announce Type: new Abstract: Structure-based drug design increasingly employs LLM agents to iteratively refine ligands against a target pocket, yet a viable ligand must satisfy two often-conflicting objectives -- binding affinity and druggability -- which single optimization steps rarely improve together.

By Zaifei Yang, Weiyu Chen, Yaqing Wang, James Kwok